Metabolism of 06-Benzylguanine, an Inactivator of 06-Alkylguanine-DNA Alkyltransferase

Cancer Research

Volumn 54, Issue 19, 1994, Pages 5123-5130

  Friedman, Henry S ^d   Chae, Mi Young ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; GUANINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; METHYLTRANSFERASE; O(6) BENZYLGUANINE; O(6) METHYLGUANINE DNA METHYLTRANSFERASE; O(6)-BENZYLGUANINE; 6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; 6 O BENZYLGUANINE; DRUG METABOLITE; ENZYME INHIBITOR; GUANINE DERIVATIVE;

ANIMAL; ARTICLE; LIVER; MALE; METABOLISM; MOUSE; MOUSE STRAIN; RAT; RAT STRAIN; TISSUE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG URINE LEVEL; ENZYME INACTIVATION; ESOPHAGUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; LUNG; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SMALL INTESTINE; SPLEEN;

ANIMAL; GUANINE; LIVER; MALE; METHYLTRANSFERASES; MICE; MICE, INBRED BALB C; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE DISTRIBUTION;

EID: 0028171184     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Pegg, A. E. Mammalian CAalkylguanine-DNA alky 1 transferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res. 50: 6119-6129, 1990.
2. Pegg, A. E. and Byers, T. Repair of DNA containing O6alkylguanine. FASEB J. 6: 2302-2310, 1992.
3. Mitra, S. and Kaina, B. Regulation of repair of alkylation damage in mammalian genomes. Prog. Nucleic Acid Res. Mol. Biol. 44: 109-142, 1993.
4. Kohn, K. W. Interstrand cross-linking of DNA by l,3-bis(2-chloroethyl)-l -nitrosourea and other l-(2-haloethyl)-l-nitrosoureas. Cancer Res. 37: 1450-1454,1977.
5. Brent, T. P. Isolation and purification of (Aalkylguanine-DNA alkyltransferase from human leukemic cells. Prevention of chloroethylnitrosourea-induced cross-links by purified enzyme. Pharmacol. Ther. 57: 121-140, 1985.
6. Robins P. Harris, A. L. Goldsmith, I. and Lindahl, T. Cross-linking of DNA induced by chloroethylnitrosourea is prevented by 06-methylguanine-DNA methyltransferase. Nucleic Acids Res. 11: 7743-7758, 1983.
7. Walker, M. C. Masters, J. R. and Margison, G. P. O6-Alkylguaninc-DNA alkyl-transferase activity and nitrosourea sensitivity in human cancer cell lines. Br. J. Cancer, 66: 840-843, 1992.
8. Dolan, M. E. Moschel, R. G. and Pegg, A. E. Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad. Sei. USA, 87: 5368-5372, 1990.
9. Moschel, R. C. McDougall, M. G. Dolan, M. E. Stine, L. and Pegg, A. E. Structural features of substituted purine derivatives compatible with depletion of human 6-alkylguanine-DNA alkyltransferase. J. Med. Chem. 35: 4486-4491, 1992.
10. Chae, M.-Y. McDougall, M. G. Dolan, M. E. Swenn, K. Pegg, A. E. and Moschel, R. C. Substituted (Abenzylguanine derivatives and their inactivation of human C-alkylguanine-DNA alkyltransferase. J. Med Chem. 37: 342-347, 1994.
11. Dolan, M. E. Mitchell, R. B. Mummert, C. Moschel, R. C. and Pegg, A. E. Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res. 51: 3367-3372, 1991.
12. Dolan, M. E. Stine, L. Mitchell, R. B. Moschel, R. C. and Pegg, A. E. Modulation of mammalian O6-alkylguanine-DNA alkyltransferase in vivo by O6-benzylguanine and its effect on the sensitivity of a human glioma tumor to l-(2-chloroethyl)-3-(4-methylcyclohexyl)-l-nitrosourea. Cancer Commun. 2: 371-377, 1990.
13. Mitchell, R. B. Moschel, R. C. and Dolan, M. E. Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to l,3-bis(2-chloroethyl)-l -nitrosourea and on DNA interstrand cross-link formation. Cancer Res. 52: 1171-1175, 1992.
14. Friedman, H. S. Dolan, M. E. Moschel, R. C. Pegg, A. E. Felker, G. M. Rich, J. Bigner, D. D. and Schold, S. C. Enhancement of nitrosourea activity in medullo-blastoma and glioblastoma multiforme. J. Natl. Cancer Inst. 84: 1926-1931, 1992.
15. Felker, G. M. Friedman, H. S. Dolan, M. E. Moschel, R. C. and Schold, C. Treatment of subcutaneous and intracranial brain tumor xenografts with O6-bctayl-guanine and l,3-bis(2-chloroethyl)-l-nitrosourea. Cancer Chemother. Pharmacol. 32: 471-476, 1993.
16. Dolan, M. E. Pegg, A. E. Moschel, R. C. and Grindey, G. B. Effect of O6-benzylguanine analogs on the sensitivity of human colon tumor xenografts to BCNU. Biochem. Pharmacol. 46: 285-290, 1993.
17. Bowles, W. A. Schneider, F. H. Lewis, L. R. and Robins, R. K. Synthesis and antitumor activity of 9-(tetrahydro-2-ruryl)purine analogs of biologically important deoxynucleosides. J. Med. Chem. 6: 471-480, 1963.
18. Bullard, D. E. Schold, S. C. Jr. Bigner, S. H. et cd. Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. J. Ncuropathol. Exp. Neurol. 40: 410-427, 1981.
19. Pfleiderer, W. and Lohrmann, R. Synthese von 2-Amino-4-alkoxy-pteridinen. Chem. Ber. 94: 12-18, 1961.
20. Domoradzki, J. Pegg, A. E. Dolan, M. E. Maher, V. M. and McCormick, J. J. Correlation between O6-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N’-nitro-N-nitrosoguanidine. Carcinogenesis (Lond.), 5: 1641-1647, 1984.
21. Dolan, M. E. Young, G. S. and Pegg, A. E. Effect of O6-alkylguanine pretreatment on the sensitivity of human colon tumor cells to the cytotoxic effects of chloroethylating agents. Cancer Res. 46: 4500-4504, 1986.
22. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem. 72: 248-254, 1976.
23. Cavalieri, L. F. and Bendich, A. The ultraviolet absorption spectra of pyrimidines and purines. J. Am. Chem. Soc. 72: 2587-2594, 1950.
24. Nebert, D. W. and Weber, W. W. Pharmacogenetics. In: W. B. Pratt and P. Taylor (eds.), Principles of Drug Action: The Basis of Pharmacology, pp. 469-531. New York: Churchill Livingstone, 1990.
25. Dolan, M. E. Pegg, A. E. Moschel, R. C. Vishnuvajjala, B. R. Flora, K. P. Grevcr, M. R. and Friedman, H. S. Biodistribution of O6-benzylguanine and its effectiveness against human brain tumor xenografts when given in polyethylene glycol or cremophor-EL. Cancer Chemother. Pharmacol. in press, 1994.
26. Weber, W. W. Levy, G. N. and Hein, D. W. Acetylation. In: G. J. Mulder (ed.), Conjugation Reaction in Drug Metabolism, pp. 163-191. Taylor and Francis Ltd. 1990.
27. Jenne, J. W. Nagasawa, H. T. and Thompson, R. D. Relationship of urinary metabolites to serum theophylline levels. Clin. Pharmacol. Ther. 19: 375-381, 1976.
28. Krenitsky, T. A. Neil, S. M. Elion, G. B. and Hitchings, G. C. A comparison of the specificities of xanthine oxidase and aldehyde oxidase. Arch. Biochem. Biophys. 150: 585-599, 1972.